Published in Dis Colon Rectum on July 01, 2009
CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int (2011) 1.62
Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg (2010) 1.48
The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women's Health Initiative. Cancer Causes Control (2014) 1.38
Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer (2010) 1.32
Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer (2013) 1.28
Microsatellite instability and survival in rectal cancer. Cancer Causes Control (2009) 1.24
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis (2010) 1.19
Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer (2009) 1.17
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer (2011) 1.12
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway. Carcinogenesis (2010) 1.11
Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev (2009) 1.10
MAP kinase genes and colon and rectal cancer. Carcinogenesis (2012) 1.08
Differences in survival between colon and rectal cancer from SEER data. PLoS One (2013) 1.06
Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer. Mutat Res (2010) 1.04
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer (2010) 1.02
Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer (2013) 1.01
Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer (2011) 0.99
Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer (2011) 0.92
Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies. J Oncol (2013) 0.92
Processed and Unprocessed Red Meat and Risk of Colorectal Cancer: Analysis by Tumor Location and Modification by Time. PLoS One (2015) 0.91
Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Variation in the CYP19A1 gene and risk of colon and rectal cancer. Cancer Causes Control (2011) 0.89
Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int J Cancer (2012) 0.88
Improved survival among colon cancer patients with increased differentially expressed pathways. BMC Med (2015) 0.87
Analysis of differentially expressed genes in human rectal carcinoma using suppression subtractive hybridization. Clin Exp Med (2011) 0.86
RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection. J Cancer Res Clin Oncol (2010) 0.86
Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. Nutr Cancer (2010) 0.86
TERT's role in colorectal carcinogenesis. Mol Carcinog (2012) 0.86
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer (2014) 0.85
Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet (2010) 0.85
Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study. Am J Gastroenterol (2010) 0.83
Alcohol consumption and rectal tumor mutations and epigenetic changes. Dis Colon Rectum (2010) 0.82
Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. Cancer Epidemiol (2011) 0.82
A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer. Carcinogenesis (2014) 0.81
Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer. Int J Mol Epidemiol Genet (2011) 0.81
The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment. Surg Today (2017) 0.81
shRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo. Int J Mol Sci (2014) 0.79
Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer. Cancer Causes Control (2010) 0.79
KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomas. J Gastrointest Oncol (2014) 0.78
Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer. World J Gastroenterol (2014) 0.78
The influence of the CHIEF pathway on colorectal cancer-specific mortality. PLoS One (2014) 0.77
Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1. Cancers (Basel) (2010) 0.77
Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran. Gut Liver (2013) 0.76
The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Oncotarget (2016) 0.75
Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome. Oncotarget (2016) 0.75
Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients. BMC Med Genet (2014) 0.75
Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment. BMC Cancer (2010) 0.75
Colorectal Cancer Prognosis Following Obesity Surgery in a Population-Based Cohort Study. Obes Surg (2016) 0.75
The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes Chromosomes Cancer (2017) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst (2000) 4.39
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol (2005) 3.48
Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Energy balance and colon cancer--beyond physical activity. Cancer Res (1997) 3.11
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08
Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev (2000) 3.05
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology (2001) 2.68
Inferring tree models for oncogenesis from comparative genome hybridization data. J Comput Biol (1999) 2.25
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol (2001) 1.79
CIMP, at last. Gastroenterology (2005) 1.74
Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer (2004) 1.59
Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer (2003) 1.55
Physical activity and colorectal cancer. Sports Med (2004) 1.55
Distance-based reconstruction of tree models for oncogenesis. J Comput Biol (2000) 1.55
APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res (2007) 1.54
Physical activity and risk of colorectal cancer in men and women. Br J Cancer (1996) 1.53
Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord (1998) 1.41
Microsatellite instability in colorectal adenomas. Gastroenterology (1997) 1.35
Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res (2000) 1.32
Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer Epidemiol Biomarkers Prev (2001) 1.27
Family history and colorectal cancer: predictors of risk. Cancer Causes Control (2003) 1.24
Dietary intake and microsatellite instability in colon tumors. Int J Cancer (2001) 1.24
Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology (2004) 1.22
Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res (2001) 1.19
Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev (2002) 1.18
Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. Mutat Res (2000) 1.12
p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry. Appl Immunohistochem Mol Morphol (2004) 1.09
Do occupational factors influence the risk of colon and rectal cancer in different ways? Cancer (1993) 1.03
Estimating an oncogenetic tree when false negatives and positives are present. Math Biosci (2002) 1.00
Plant foods and differences between colon and rectal cancers. Eur J Cancer Prev (2002) 0.96
Reproductive factors and colon cancer: the influences of age, tumor site, and family history on risk (Utah, United States). Cancer Causes Control (1995) 0.92
Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors. Cancer Sci (2008) 0.89
Sex-specific differences in colon cancer associated with p53 mutations. Nutr Cancer (2004) 0.82
The clinical features of the hereditary and nonhereditary polyposis syndromes. Surg Oncol Clin N Am (1996) 0.80
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics (2008) 4.41
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell (2011) 3.47
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials (2002) 3.41
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08
Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat (2005) 2.75
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res (2009) 2.59
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst (2013) 2.46
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat (2007) 2.41
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol (2010) 2.31
First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther (2009) 2.09
It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park) (2013) 2.07
Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A (2008) 2.06
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics (2012) 2.01
Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev (2009) 1.95
Estimating kinship in admixed populations. Am J Hum Genet (2012) 1.95
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int (2008) 1.88
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst (2008) 1.81
Increases in plasma carotenoid concentrations in response to a major dietary change in the women's healthy eating and living study. Cancer Epidemiol Biomarkers Prev (2006) 1.78
Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J Nutr (2004) 1.75
The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control (2008) 1.70
Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause (2014) 1.67
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr (2009) 1.66
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol (2008) 1.64
Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control (2008) 1.60
Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer (2004) 1.59
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst (2002) 1.58
Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol (2008) 1.56
Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer (2003) 1.55
APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res (2007) 1.54
California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health (2006) 1.53
Amplification and overexpression of E2F3 in human bladder cancer. Oncogene (2004) 1.52
Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control (2003) 1.52
Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators. Acad Med (2015) 1.52
MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer (2010) 1.51
Physical activity patterns and obesity in Hispanic and non-Hispanic white women. Med Sci Sports Exerc (2006) 1.51
NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat (2006) 1.50
Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative. Menopause (2012) 1.50
Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer (2002) 1.46
Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res (2005) 1.46
Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol (2004) 1.44
Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat (2010) 1.42
Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene (2003) 1.40
Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol (2005) 1.40
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis (2012) 1.40
Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer (2004) 1.39
Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am J Clin Nutr (2008) 1.38
Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.37
Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat (2011) 1.36
IL6 genotypes and colon and rectal cancer. Cancer Causes Control (2007) 1.36
Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer (2009) 1.34
Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr (2012) 1.32
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Diet composition and risk of overweight and obesity in women living in the southwestern United States. J Am Diet Assoc (2007) 1.28
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis (2007) 1.28
Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma. Cell Cycle (2006) 1.27
Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.27
Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer (2006) 1.26
Microsatellite instability and survival in rectal cancer. Cancer Causes Control (2009) 1.24
Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes Chromosomes Cancer (2002) 1.23
Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer (2010) 1.22
Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev (2004) 1.22
Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern. J Nutr (2007) 1.21
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat (2011) 1.21
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer (2011) 1.20
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis (2010) 1.19